Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Cash from Operations (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Cash from Operations for 2 consecutive years, with 2777477.0 as the latest value for Q4 2023.

  • Quarterly Cash from Operations rose 5.66% to 2777477.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 8313870.0 through Dec 2023, down 7.39% year-over-year, with the annual reading at 6053575.0 for FY2025, 22.6% up from the prior year.
  • Cash from Operations hit 2777477.0 in Q4 2023 for Bluejay Diagnostics, down from 1125066.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1125066.0 in Q3 2023 to a low of 2944243.0 in Q4 2022.